Terms: = Bone cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
100 results:
1. [Drastic changes in the treatment of metastatic prostate cancer].
Thellenberg Karlsson C; Ståhl O
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38651316
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Postoperative Recurrence of Bilateral Breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
[TBL] [Abstract] [Full Text] [Related]
3. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease.
Ringdén O; Sadeghi B
Stem Cells; 2024 Apr; 42(4):291-300. PubMed ID: 38204331
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
[TBL] [Abstract] [Full Text] [Related]
5. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
[TBL] [Abstract] [Full Text] [Related]
6. Changes in bone Density in Carriers of brca1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy.
Chan LN; Chen LM; Goldman M; Mak JS; Bauer DC; Boscardin J; Schembri M; Bae-Jump V; Friedman S; Jacoby VL
Obstet Gynecol; 2023 Jul; 142(1):160-169. PubMed ID: 37290104
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
[TBL] [Abstract] [Full Text] [Related]
8. Differences between zoledronic acid and denosumab for breast cancer treatment.
Ishikawa T
J Bone Miner Metab; 2023 May; 41(3):301-306. PubMed ID: 36879056
[TBL] [Abstract] [Full Text] [Related]
9. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
[TBL] [Abstract] [Full Text] [Related]
10. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
11. Low Expression of brca1 as a Potential Relapse Predictor in B-Cell Acute Lymphoblastic Leukemia.
Villegas-Ruíz V; Medina-Vera I; Arellano-Perdomo P; Castillo-Villanueva A; Galván-Diaz CA; Paredes-Aguilera R; Rivera-Luna R; Juárez-Méndez S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e167-e173. PubMed ID: 36730467
[TBL] [Abstract] [Full Text] [Related]
12. A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Fornarini G; Rebuzzi SE; Buti S; Rescigno P; Merseburger A; Sternberg CN; de Giorgi U; Basso U; Maruzzo M; Giannatempo P; Ponzano M; Giunta EF; Catalano F; Murianni V; Damassi A; Cremante M; Gandini A; Puglisi S; Llaja Obispo MA; Signori A; Banna GL
Minerva Urol Nephrol; 2023 Jun; 75(3):308-318. PubMed ID: 36511379
[TBL] [Abstract] [Full Text] [Related]
13. RANKL and RANK in cancer Therapy.
Onji M; Penninger JM
Physiology (Bethesda); 2023 May; 38(3):0. PubMed ID: 36473204
[TBL] [Abstract] [Full Text] [Related]
14. Real-world treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights Study.
Mycock K; Hanson KA; Taylor-Stokes G; Milligan G; Atkinson C; Mitra D; Preciado S; Law EH
Clin Ther; 2022 Dec; 44(12):1588-1601. PubMed ID: 36456385
[TBL] [Abstract] [Full Text] [Related]
15. Phase I Study of Niraparib in Combination with Radium-223 for the treatment of Metastatic Castrate-Resistant Prostate cancer.
Quinn Z; Leiby B; Sonpavde G; Choudhury AD; Sweeney C; Einstein D; Szmulewitz R; Sartor O; Knudsen K; Yang ES; Kelly WK
Clin Cancer Res; 2023 Jan; 29(1):50-59. PubMed ID: 36321991
[TBL] [Abstract] [Full Text] [Related]
16. The DNA damage induced immune response: Implications for cancer therapy.
Barros EM; McIntosh SA; Savage KI
DNA Repair (Amst); 2022 Dec; 120():103409. PubMed ID: 36308822
[TBL] [Abstract] [Full Text] [Related]
17. brca1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
Maurer LM; Daley JD; Mukherjee E; Venier RE; Julian CM; Bailey NG; Jacobs MF; Kumar-Sinha C; Raphael H; Periyapatna N; Weiss K; Janeway KA; Mody R; Lucas PC; McAllister-Lucas LM; Bailey KM
Cancer Res Commun; 2022 Apr; 2(4):220-232. PubMed ID: 36187937
[TBL] [Abstract] [Full Text] [Related]
18. Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database.
Franko J; Yin J; Adams RA; Zalcberg J; Fiskum J; Van Cutsem E; Goldberg RM; Hurwitz H; Bokemeyer C; Kabbinavar F; Curtis A; Meyers J; Chibaudel B; Yoshino T; de Gramont A; Shi Q;
Eur J Cancer; 2022 Oct; 174():142-152. PubMed ID: 35994794
[TBL] [Abstract] [Full Text] [Related]
19. [A Case of Metastatic Breast cancer with brca1 Mutation after Breast Reconstruction and Pregnancy].
Suzuki T; Hashimoto N; Yokoyama K; Yoshida T; Yamauchi Y; Sawano T; Ohashi M; Kimura A; Kato M; Umehara Y; Murata A; Takahash K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1840-1842. PubMed ID: 35046348
[TBL] [Abstract] [Full Text] [Related]
20. Clinical efficacy of palbociclib-based therapy in women with HR+/HER2- metastatic breast cancer in the real-world setting for Chinese women: a comparison with the iris study.
Shangguan CF; Jiang M; Yang C; Lou GY; Li YT; Qu Q
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):6138-6148. PubMed ID: 34661274
[TBL] [Abstract] [Full Text] [Related]
[Next]
